Yulin Lin
- Hepatology top 2%
- Hepatitis C virus research 10
- Biomaterials top 5%
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 19
- Pharmacology top 2%
-
- Gastric Cancer Management and Outcomes 11
-
- Genetic factors in colorectal cancer 10
-
- Genomics and Phylogenetic Studies 10
-
- Hepatitis B Virus Studies 10
-
- Advancements in Battery Materials 9
- Advanced Battery Materials and Technologies 7
- Co-authors
- Hui YaoShilin ChenJianping HanChang LiuXiwen LiYing LiLinchun ShiJingyuan Song
- Journals
- Journal of Ethnopharmacology (5 papers)PLoS ONE (5 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Yulin Lin
144 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Hepatology 321
- Complementary and alternative medicine 234
- Biomaterials 359
- Oncology 640
- Pharmacology 189
Countries citing papers authored by Yulin Lin
This map shows the geographic impact of Yulin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulin Lin more than expected).
Fields of papers citing papers by Yulin Lin
This network shows the impact of papers produced by Yulin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulin Lin. The network helps show where Yulin Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yulin Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 20 | |
| 5 | 2022 | 66 | |
| 6 | 2022 | 48 | |
| 7 | 2021 | 186 | |
| 8 | 2021 | 16 | |
| 9 | 2021 | 18 | |
| 10 | 2019 | 77 | |
| 11 | Cetuximab Might Be Detrimental to Metastatic Colorectal Cancer Patients with KRAS Codon 12 Mutations. | 2015 | 3 |
| 12 | 2015 | 7 | |
| 13 | 2015 | 84 | |
| 14 | 2015 | 7 | |
| 15 | Expedient identification of Magnoliaceae species by DNA barcoding | 2014 | 10 |
| 16 | 2013 | 126 | |
| 17 | 2012 | 60 | |
| 18 | 2011 | 19 | |
| 19 | 2010 | 5 | |
| 20 | Counter measures to overcome the present inadequate means for the protection of near extinct Species of Chinese medicinal plants | 2000 | 5 |
About Yulin Lin
Yulin Lin is a scholar working on Hepatology, Oncology, Occupational Therapy, Pharmacology and Microbiology, having authored 152 papers that have together received 4.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (19 papers), Gastric Cancer Management and Outcomes (11 papers), Genetic factors in colorectal cancer (10 papers), Hepatitis C virus research (10 papers), Genomics and Phylogenetic Studies (10 papers), Hepatitis B Virus Studies (10 papers), Advancements in Battery Materials (9 papers) and Advanced Battery Materials and Technologies (7 papers). The work is most often cited by research in Hepatology (321 citations), Complementary and alternative medicine (234 citations), Biomaterials (359 citations), Oncology (640 citations) and Pharmacology (189 citations). Yulin Lin has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Hui Yao, Shilin Chen, Jianping Han, Chang Liu, Xiwen Li, Ying Li, Linchun Shi, Jingyuan Song, Kun Luo and Yingjie Zhu. Their work appears in journals such as Journal of Ethnopharmacology, PLoS ONE, Journal of Clinical Oncology, Scientific Reports and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.